EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Stem Cell Therapy in Thromboangiitis Obliterans: A Review of Clinical Outcomes

Jithin Jagan Sebastian, M K Ayyappan

Indian Journal of Vascular and Endovascular Surgery · 2026-01 · 13 (1) · 80-91

DOI: 10.4103/ijves.ijves_156_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Vascular and Endovascular Surgery, online erschienen am 21.03.2026. Verfasst von Jithin Jagan Sebastian und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thromboangiitis obliterans (TAO) is a nonatherosclerotic vasculitis that predominantly affects young male smokers. Patients typically present with symptomatic peripheral arterial disease, most often manifesting as chronic limb-threatening ischemia, and frequently have no viable revascularization options or have failed revascularization. Over the past two decades, this high-risk cohort has been the focus of stem cell-based therapies aimed at improving clinical outcomes and reducing amputation rates. Early preclinical studies in the 1990s established the foundation for subsequent clinical investigations. This rapid systematic review synthesizes the findings of 19 clinical studies encompassing 682 patients with TAO. Considerable heterogeneity was observed across studies, including inconsistent reporting of smoking cessation status, variable diagnostic criteria for TAO, and differences in stem cell transplantation protocols and outcome measures. Overall, stem cell therapy demonstrated potential for improving clinical outcomes in TAO; however, robust randomized controlled trials with standardized methodologies are required to establish definitive efficacy in this patient population.

Zitieren

APA

Sebastian, J. J., & Ayyappan, M. K. (2026). Stem Cell Therapy in Thromboangiitis Obliterans: A Review of Clinical Outcomes. Indian Journal of Vascular and Endovascular Surgery, 13(1), 80-91. https://doi.org/10.4103/ijves.ijves_156_25

Vancouver

Sebastian JJ, Ayyappan MK. Stem Cell Therapy in Thromboangiitis Obliterans: A Review of Clinical Outcomes. Indian Journal of Vascular and Endovascular Surgery. 2026;13(1):80-91. doi:10.4103/ijves.ijves_156_25

BibTeX
@article{Sebastian2026,
  author = {Sebastian, Jithin Jagan and Ayyappan, M K},
  title = {Stem Cell Therapy in Thromboangiitis Obliterans: A Review of Clinical Outcomes},
  journal = {Indian Journal of Vascular and Endovascular Surgery},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {80--91},
  doi = {10.4103/ijves.ijves_156_25}
}
Kostenlos starten →